IMGT analysis of the human IGH locus: unveiling novel polymorphisms and copy number variations in 15 genome assemblies from diverse ancestral backgrounds.

IMGT analysis of the human IGH locus: unveiling novel polymorphisms and copy number variations in 15 genome assemblies from diverse ancestral backgrounds.

Publication date: Sep 01, 2025

Unraveling the genetic complexity of the human immunoglobulin heavy (IGH) chain locus provides valuable insights into the mechanisms underlying the efficacy and specificity of the adaptive immune response. Despite its crucial role, the IGH locus remains insufficiently characterized, with its allelic diversity and polymorphisms inadequately investigated. In this study, we present an analysis of the human IGH locus, incorporating 15 human genome assemblies from diverse ancestries, including African, European, Asian, Saudi, and mixed backgrounds. Through our examination of both maternal and paternal assemblies, we uncover novel IGH alleles, copy number variations (CNV), and polymorphisms, particularly within the variable (IGHV) region. Our findings reveal extensive and previously uncharacterized genetic variability in the constant (IGHC) region and distinct IMGT CNV forms across individuals. This research contributes to a significant enrichment of the IMGT IGH reference directory, databases, tools and web resources, and lays the groundwork for an IMGT haplotype database which can be progressively enriched as additional datasets become available. Such a resource promises to propel personalized immunogenomics forward, with exciting applications in cancer immunotherapy, COVID-19, and other immune-related diseases.

Open Access PDF

Concepts Keywords
African Alleles
Immunogenomics Genome, Human
Saudi Haplotypes
Unveiling Humans
Valuable Immunoglobulin Heavy Chains
Immunoglobulin Heavy Chains
Polymorphism, Genetic

Semantics

Type Source Name
disease IDO adaptive immune response
disease IDO role
disease MESH cancer
disease MESH COVID-19
drug DRUGBANK Methyl isocyanate
drug DRUGBANK Creatinolfosfate
drug DRUGBANK Pinaverium
drug DRUGBANK Coenzyme M
disease IDO production
pathway REACTOME Reproduction
pathway REACTOME Translation
disease IDO site
pathway REACTOME Immune System
disease IDO process
disease IDO susceptibility
disease MESH autoimmune diseases
disease MESH infectious diseases
disease MESH tic
drug DRUGBANK Cysteamine
disease IDO quality
drug DRUGBANK Methionine
drug DRUGBANK Alteplase
drug DRUGBANK L-Valine
drug DRUGBANK Diethylstilbestrol
drug DRUGBANK Ilex paraguariensis leaf
drug DRUGBANK Fenamole
drug DRUGBANK Ademetionine
drug DRUGBANK Acetylcholine
drug DRUGBANK L-Leucine
disease IDO homo sapiens
drug DRUGBANK L-Phenylalanine
drug DRUGBANK Glycine
drug DRUGBANK L-Threonine
drug DRUGBANK L-Isoleucine
drug DRUGBANK L-Arginine
drug DRUGBANK L-Cysteine
disease MESH tryptophan
drug DRUGBANK L-Tryptophan
drug DRUGBANK Glutamic Acid
drug DRUGBANK L-Aspartic Acid
drug DRUGBANK Proline
disease IDO cell
disease IDO history
disease IDO immune response
disease MESH agammaglobulinemia
disease MESH immune tolerance
disease MESH inflammation
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
disease MESH IgG4 related disease
drug DRUGBANK Methylergometrine
disease IDO host
disease MESH infection
drug DRUGBANK Silver
drug DRUGBANK Diphenylpyraline
disease MESH Allergy
drug DRUGBANK Nonoxynol-9
disease MESH breast cancer
pathway KEGG Breast cancer
disease MESH myasthenia gravis
disease MESH thymoma
disease MESH Asthma
pathway KEGG Asthma
disease MESH Cholangiocarcinoma
disease MESH malignant melanoma
disease MESH pancreatic cancer
pathway KEGG Pancreatic cancer
disease MESH autoimmune pancreatitis
pathway KEGG Melanoma
disease MESH syndrome

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *